161 related articles for article (PubMed ID: 38674259)
1. A Novel Approach to Cardiac Magnetic Resonance Scar Characterization in Patients Affected by Cardiac Amyloidosis: A Pilot Study.
Alfieri M; Guerra F; Lofiego C; Fogante M; Ciliberti G; Vagnarelli F; Barbarossa A; Principi S; Stronati G; Volpato G; Compagnucci P; Valeri Y; Tofoni P; Brugiatelli L; Capodaglio I; Esposto Pirani P; Argalia G; Schicchi N; Messano L; Centanni M; Giovagnoni A; Perna GP; Dello Russo A; Casella M
Medicina (Kaunas); 2024 Apr; 60(4):. PubMed ID: 38674259
[No Abstract] [Full Text] [Related]
2. Patterns of CMR measured longitudinal strain and its association with late gadolinium enhancement in patients with cardiac amyloidosis and its mimics.
Williams LK; Forero JF; Popovic ZB; Phelan D; Delgado D; Rakowski H; Wintersperger BJ; Thavendiranathan P
J Cardiovasc Magn Reson; 2017 Aug; 19(1):61. PubMed ID: 28784140
[TBL] [Abstract][Full Text] [Related]
3. Characterizing cardiac involvement in amyloidosis using cardiovascular magnetic resonance diffusion tensor imaging.
Gotschy A; von Deuster C; van Gorkum RJH; Gastl M; Vintschger E; Schwotzer R; Flammer AJ; Manka R; Stoeck CT; Kozerke S
J Cardiovasc Magn Reson; 2019 Sep; 21(1):56. PubMed ID: 31484544
[TBL] [Abstract][Full Text] [Related]
4. Tissue mapping by cardiac magnetic resonance imaging for the prognostication of cardiac amyloidosis: A systematic review and meta-analysis.
Cai S; Haghbayan H; Chan KKW; Deva DP; Jimenez-Juan L; Connelly KA; Ng MY; Yan RT; Yan AT
Int J Cardiol; 2024 May; 403():131892. PubMed ID: 38382853
[TBL] [Abstract][Full Text] [Related]
5. Non-invasive diagnosis of transthyretin cardiac amyloidosis utilizing typical late gadolinium enhancement pattern on cardiac magnetic resonance and light chains.
Slivnick JA; Alvi N; Singulane CC; Scheetz S; Goyal A; Patel H; Sarswat N; Addetia K; Fernandes F; Vieira MLC; Cafezeiro CRF; Carvalhal SF; Simonetti OP; Singh J; Lang RM; Zareba KM; Patel AR
Eur Heart J Cardiovasc Imaging; 2023 May; 24(6):829-837. PubMed ID: 36624559
[TBL] [Abstract][Full Text] [Related]
6. Towards a Diagnosis of Cardiac Amyloidosis: Single Center Experience with
Saleem M; Sadat B; Van Harn M; Ananthasubramaniam K
Medicina (Kaunas); 2023 Feb; 59(2):. PubMed ID: 36837580
[No Abstract] [Full Text] [Related]
7. Regional myocardial microvascular dysfunction in cardiac amyloid light-chain amyloidosis: assessment with 3T cardiovascular magnetic resonance.
Li R; Yang ZG; Wen LY; Liu X; Xu HY; Zhang Q; Guo YK
J Cardiovasc Magn Reson; 2016 Apr; 18():16. PubMed ID: 27048459
[TBL] [Abstract][Full Text] [Related]
8. Scar Characterization to Predict Life-Threatening Arrhythmic Events and Sudden Cardiac Death in Patients With Cardiac Resynchronization Therapy: The GAUDI-CRT Study.
Acosta J; Fernández-Armenta J; Borràs R; Anguera I; Bisbal F; Martí-Almor J; Tolosana JM; Penela D; Andreu D; Soto-Iglesias D; Evertz R; Matiello M; Alonso C; Villuendas R; de Caralt TM; Perea RJ; Ortiz JT; Bosch X; Serra L; Planes X; Greiser A; Ekinci O; Lasalvia L; Mont L; Berruezo A
JACC Cardiovasc Imaging; 2018 Apr; 11(4):561-572. PubMed ID: 28780194
[TBL] [Abstract][Full Text] [Related]
9. Light-Chain Cardiac Amyloidosis: Cardiac Magnetic Resonance for Assessing Response to Chemotherapy.
Guo Y; Li X; Gao Y; Shen K; Lin L; Wang J; Cao J; Zhang Z; Wan K; Zhou XY; Chen Y; Zhang LJ; Li J; Wang Y
Korean J Radiol; 2024 May; 25(5):426-437. PubMed ID: 38685733
[TBL] [Abstract][Full Text] [Related]
10. Myocardial Edema and Prognosis in Amyloidosis.
Kotecha T; Martinez-Naharro A; Treibel TA; Francis R; Nordin S; Abdel-Gadir A; Knight DS; Zumbo G; Rosmini S; Maestrini V; Bulluck H; Rakhit RD; Wechalekar AD; Gilbertson J; Sheppard MN; Kellman P; Gillmore JD; Moon JC; Hawkins PN; Fontana M
J Am Coll Cardiol; 2018 Jun; 71(25):2919-2931. PubMed ID: 29929616
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of left atrial function in systemic light-chain amyloidosis: a cardiac magnetic resonance study.
Mohty D; Boulogne C; Magne J; Varroud-Vial N; Martin S; Ettaif H; Fadel BM; Bridoux F; Aboyans V; Damy T; Jaccard A
Eur Heart J Cardiovasc Imaging; 2016 Sep; 17(9):961-9. PubMed ID: 27194782
[TBL] [Abstract][Full Text] [Related]
12. Left ventricular structure and function in transthyretin-related versus light-chain cardiac amyloidosis.
Quarta CC; Solomon SD; Uraizee I; Kruger J; Longhi S; Ferlito M; Gagliardi C; Milandri A; Rapezzi C; Falk RH
Circulation; 2014 May; 129(18):1840-9. PubMed ID: 24563469
[TBL] [Abstract][Full Text] [Related]
13. Comparison of different types of cardiac amyloidosis by cardiac magnetic resonance imaging.
Kristen AV; aus dem Siepen F; Scherer K; Kammerer R; Andre F; Buss SJ; Bauer R; Lehrke S; Voss A; Giannitsis E; Katus HA; Steen H
Amyloid; 2015; 22(2):132-41. PubMed ID: 26053103
[TBL] [Abstract][Full Text] [Related]
14. Entropy as a Novel Measure of Myocardial Tissue Heterogeneity for Prediction of Ventricular Arrhythmias and Mortality in Post-Infarct Patients.
Androulakis AFA; Zeppenfeld K; Paiman EHM; Piers SRD; Wijnmaalen AP; Siebelink HJ; Sramko M; Lamb HJ; van der Geest RJ; de Riva M; Tao Q
JACC Clin Electrophysiol; 2019 Apr; 5(4):480-489. PubMed ID: 31000102
[TBL] [Abstract][Full Text] [Related]
15. Left atrial strain imaging differentiates cardiac amyloidosis and hypertensive heart disease.
Rausch K; Scalia GM; Sato K; Edwards N; Lam AK; Platts DG; Chan J
Int J Cardiovasc Imaging; 2021 Jan; 37(1):81-90. PubMed ID: 32728989
[TBL] [Abstract][Full Text] [Related]
16. Atrial function and geometry differences in transthyretin versus immunoglobulin light chain amyloidosis: a cardiac magnetic resonance study.
Palmer C; Truong VT; Slivnick JA; Wolking S; Coleman P; Mazur W; Zareba KM
Sci Rep; 2022 Jan; 12(1):140. PubMed ID: 34996915
[TBL] [Abstract][Full Text] [Related]
17. Incidence and risk factors for pacemaker implantation in light-chain and transthyretin cardiac amyloidosis.
Porcari A; Rossi M; Cappelli F; Canepa M; Musumeci B; Cipriani A; Tini G; Barbati G; Varrà GG; Morelli C; Fumagalli C; Zampieri M; Argirò A; Vianello PF; Sessarego E; Russo D; Sinigiani G; De Michieli L; Di Bella G; Autore C; Perfetto F; Rapezzi C; Sinagra G; Merlo M
Eur J Heart Fail; 2022 Jul; 24(7):1227-1236. PubMed ID: 35509181
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic value of cardiovascular magnetic resonance in comparison to endomyocardial biopsy in cardiac amyloidosis: a multi-centre study.
Chatzantonis G; Bietenbeck M; Elsanhoury A; Tschöpe C; Pieske B; Tauscher G; Vietheer J; Shomanova Z; Mahrholdt H; Rolf A; Kelle S; Yilmaz A
Clin Res Cardiol; 2021 Apr; 110(4):555-568. PubMed ID: 33170349
[TBL] [Abstract][Full Text] [Related]
19. Noncontrast Magnetic Resonance for the Diagnosis of Cardiac Amyloidosis.
Baggiano A; Boldrini M; Martinez-Naharro A; Kotecha T; Petrie A; Rezk T; Gritti M; Quarta C; Knight DS; Wechalekar AD; Lachmann HJ; Perlini S; Pontone G; Moon JC; Kellman P; Gillmore JD; Hawkins PN; Fontana M
JACC Cardiovasc Imaging; 2020 Jan; 13(1 Pt 1):69-80. PubMed ID: 31202744
[TBL] [Abstract][Full Text] [Related]
20. Causes and Consequences of Longitudinal LV Dysfunction Assessed by 2D Strain Echocardiography in Cardiac Amyloidosis.
Ternacle J; Bodez D; Guellich A; Audureau E; Rappeneau S; Lim P; Radu C; Guendouz S; Couetil JP; Benhaiem N; Hittinger L; Dubois-Randé JL; Plante-Bordeneuve V; Mohty D; Deux JF; Damy T
JACC Cardiovasc Imaging; 2016 Feb; 9(2):126-38. PubMed ID: 26777222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
